These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9704916)

  • 1. The influence of penetration enhancers on the volume instilled of eye drops.
    Van Santvliet L; Ludwig A
    Eur J Pharm Biopharm; 1998 Mar; 45(2):189-98. PubMed ID: 9704916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of eye drops dispensing and dose variability by using plastic dropper tips.
    Sklubalová Z; Zatloukal Z
    Drug Dev Ind Pharm; 2006 Feb; 32(2):197-205. PubMed ID: 16537200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the physico-chemical properties of ophthalmic viscolysers on the weight of drops dispensed from a flexible dropper bottle.
    Van Santvliet L; Ludwig A
    Eur J Pharm Sci; 1999 Mar; 7(4):339-45. PubMed ID: 9971918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic study of factors affecting eye drop size and dosing variability.
    Sklubalová Z; Zatloukal Z
    Pharmazie; 2005 Dec; 60(12):917-21. PubMed ID: 16398268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of plastic eye dropper tips using Harkins and Brown's factor.
    Sklubalová Z; Zatloukal Z
    Pharmazie; 2007 Oct; 62(10):750-5. PubMed ID: 18236779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of eye drop size.
    Van Santvliet L; Ludwig A
    Surv Ophthalmol; 2004; 49(2):197-213. PubMed ID: 14998692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment.
    Kumar S; Karki R; Meena M; Prakash T; Rajeswari T; Goli D
    J Adv Pharm Technol Res; 2011 Jul; 2(3):192-4. PubMed ID: 22171317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic versus brand-name North American topical glaucoma drops.
    Mammo ZN; Flanagan JG; James DF; Trope GE
    Can J Ophthalmol; 2012 Feb; 47(1):55-61. PubMed ID: 22333853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility of a commercially available low-density polyethylene eye-drop container with antimicrobial preservatives and potassium ascorbate.
    Barnes AR
    J Clin Pharm Ther; 1995 Dec; 20(6):341-4. PubMed ID: 8847373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial contamination of drops and dropper tips of in-use multidose eye drop bottles.
    Høvding G; Sjursen H
    Acta Ophthalmol (Copenh); 1982 Apr; 60(2):213-22. PubMed ID: 6753455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of application systems for autologous serum eye drops.
    Spaniol K; Koerschgen L; Sander O; Koegler G; Geerling G
    Curr Eye Res; 2014 Jun; 39(6):571-9. PubMed ID: 24400979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of dose-uniformity of samples delivered from paediatric oral droppers.
    Brown D; Ford JL; Nunn AJ; Rowe PH
    J Clin Pharm Ther; 2004 Dec; 29(6):521-9. PubMed ID: 15584940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of drop size from multi-dose eye drop bottles: is it cause for concern?
    German EJ; Hurst MA; Wood D
    Eye (Lond); 1999; 13 ( Pt 1)():93-100. PubMed ID: 10396391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant solutions and porous substrates: spreading and imbibition.
    Starov VM
    Adv Colloid Interface Sci; 2004 Nov; 111(1-2):3-27. PubMed ID: 15571660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the influence of auxiliary substances on the physico-chemical characteristics of ophthalmic drugs. Part I. Studies on the influence of auxiliary substances on the critical micellar concentration of surfactants solutions in eye drops containing sulphacetamidum natricum.
    Pluta J; Meler J
    Acta Pol Pharm; 2002; 59(4):247-52. PubMed ID: 12403298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tear fluid-eye drops compatibility assessment using surface tension.
    Hotujac Grgurević M; Juretić M; Hafner A; Lovrić J; Pepić I
    Drug Dev Ind Pharm; 2017 Feb; 43(2):275-282. PubMed ID: 27645109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of Successful Eyedrop Instillation Rates and Analysis of Drop Positions Using High-speed Digital Video Recording System].
    Ikeda H; Takamoto A; Ikeda J; Kohno K; Nakatsuma A; Tokumura T; Mori K; Iihara N; Houchi H; Ninomiya M
    Yakugaku Zasshi; 2020 Dec; 140(12):1455-1462. PubMed ID: 32999129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of formulation of hipromellose eye drops (artificial tears)].
    Inkeniene AM; Klimas R; Briedis V; Maciulevicius J
    Medicina (Kaunas); 2003; 39(1):77-82. PubMed ID: 12576769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery.
    Kaur IP; Smitha R
    Drug Dev Ind Pharm; 2002 Apr; 28(4):353-69. PubMed ID: 12056529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.